Bio News
Total investment of 330 billion won aims to reduce reliance on Chinese APIs Shared infrastructure to lower production costs
India will invest a total of 330 billion won to develop the 1,400-acre Haroli active pharmaceutical ingredient (API) park in an effort to reduce its dependence on APIs from China. The project aims to lower entry barriers for individual manufacturers and reduce production costs by investing approximately 190 billion won in shared infrastructure. Construction of basic infrastructure, including roads and bridges, is underway, and the park, along with facilities being developed in Gujarat and Andhra Pradesh, is expected to contribute to stabilizing India’s pharmaceutical supply chain.
BIOBOOK TEAM
biobookmedia@biobook.co.krMerck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
Ministry of Trade, Industry and Energy signs agreement to promote biotech and medical devices in Gangwon; site visit set for the 14th
RDA develops technology to produce anti-inflammatory exosomes for pets and files patent application
Merck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
